{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-107152","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2026-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.243593+00:00","generated_at":"2026-05-15T11:37:00.284125+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CytomX reports 2025 revenue $76.2M, down 45% YoY; cash $137.1M; Astellas collaboration ends","bullets":["Revenue $76.2M (down from $138.1M in 2024) on completion of BMS collaboration and lower collaboration milestones.","Cash and investments $137.1M at Dec 31, 2025, up from $100.6M; cash runway to Q2 2027.","Astellas terminated preclinical alliance effective Q2 2026; research with BMS, Amgen, Regeneron, Moderna continues.","Varseta-M Phase 1 data positive; FDA alignment for potential registrational trial in late-line CRC targeted mid-2026.","CX-801 Phase 1 combo with KEYTRUDA in melanoma initial proof-of-concept data expected by end of 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-107152","json":"https://secwatch.observer/filing/0001193125-26-107152.json","markdown":"https://secwatch.observer/filing/0001193125-26-107152.md","text":"https://secwatch.observer/filing/0001193125-26-107152.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312526107152/0001193125-26-107152-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312526107152/ctmx-20260316.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:37:00.284125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}